Abstract:Introduction Activating Signal Cointegrator 1 Complex, Subunit 3 ( ASCC3 ) has been implicated in the pathogenesis of neurodevelopmental disorders and neuromuscular diseases (MIM: 620700). This paper analyzes the clinical manifestations of three patients with developmental delay caused by ASCC3 genetic variation. Additionally, we discuss the previously reported clinical features of these patients along with our own findings, thereby enhancing our understanding of these genetic disorders and providing valuable insights into diagnosis, treatment, and potential interventions for affected individuals. Methods In this study, we utilized trio-whole-exome sequencing (Trio-WES) and trio-copy number variations sequencing (Trio-CNV-seq) to analyze three unique families diagnosed with developmental delay caused by variation in ASCC3 . Additionally, we retrospectively examined eleven previously reported ASCC3 genetic variations exhibiting similar clinical features. Results Proband I (family 1) and Proband III (family 3) exhibited global developmental delays, characterized by intellectual disability, motor impairment, language retardation, lower muscle strength, and reduced muscle tone in their extremities. Proband II (family 2) presented poor response and dysphagia during feeding within 7 days after birth, clinical examination displayed short limbs, long trunk proportions, and clenched fists frequently observed alongside high muscle tone in his limbs -all indicative signs of developmental delay. Trio-WES revealed compound heterozygous variants in ASCC3 inherited from their parents. Proband I carried c. [489 dup]; [1897C>T], proband II carried c. [2314C>T]; [5002T>A], and proband III carried c. [5113G>T]; [718delG] variations, respectively. Conclusion This study present the first report of Chinese children carrying compound heterozygous genetic variants in ASCC3 with LOF variants, elucidating the relationship between these variants and various aspects of intellectual disability. This novel finding expands the existing spectrum of ASCC3 variations.

Congenital myasthenic syndromes in two male siblings born to healthy consanguineous parents: a case report

Clinical analysis and gene mutation screening of CLCN1 in two myotonia congenita families

Identification of LAMA2 Compound Heterozygous Variants: a Case Report

Novel chloride channel gene mutations in two unrelated Chinese families with myotonia congenita.

Congenital Myopathy with Type 1 Fiber Predominance in Two Children

Core myopathy in two siblings with a biallelic variant in the CACNA1S gene-A case series study

COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum

Congenital myasthenic syndromes

Congenital Myasthenic Syndrome associated with acetylcholine receptor deficiency: case report and review of the literature

Congenital myotonic dystrophy in Britain. II. Genetic basis.

Genetic analysis of a family affected by congenital myasthenic syndrome due to a Novel mutation in the SLC5A7 gene

X-linked myotubular myopathy in a family of two infant siblings: A case report and review

Case report: Dihydropyridine receptor (CACNA1S) congenital myopathy, a novel phenotype with early onset periodic paralysis

Case report and literature review: Novel compound heterozygous <i>FIG4</i> variants causing both of peripheral and central nervous system defects

Current status of the congenital myasthenic syndromes

Clinical and Genetic Features of Infancy-Onset Congenital Myopathies from a Chinese Paediatric Centre

A Case of a Newborn With Nemaline Myopathy From Al-Qunfudhah City, Saudi Arabia

Case report: Second report of neuromuscular syndrome caused by biallelic variants in ASCC3

Congenital myasthenic syndrome 22 due to PREPL gene mutation in 2 patients: case report and literature review

Nemaline Myopathy With a Compound Heterozygous Mutation: A Case Report

Congenital myasthenia syndrome in a Chinese family with mutations in MUSK: A hotspot mutation and literature review.